CLEC4D and osteoporosis: This activation leads to the inhibition of osteoblast differentiation and the enhancement of osteoclast-mediated bone resorption, thereby contributing to bone loss [33,34], while C-type lectin receptor signaling modulates osteoporosis progression by regulating osteoclast activity and influencing the immune responses within bone tissue [35].